Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Submitted by
admin
on October 26, 2011 - 6:12pm
Source:
Bloomberg
News Tags:
Bristol-Myers Squibb
diabetes
FDA
AstraZeneca
Dapagliflozin
Headline:
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Do Not Allow Advertisers to Use My Personal information
